Enveric Biosciences (ENVB) Revenue & Revenue Breakdown


OverviewOwnershipFinancialsChart

Enveric Biosciences Revenue Highlights


00

Enveric Biosciences Revenue by Period


Enveric Biosciences Revenue by Year

DateRevenueChange
2023-12-31-100.00%
2022-12-31-100.00%
2021-12-31-100.00%
2020-12-31--100.00%
2019-12-31$39.91M-7.17%
2018-12-31$43.00M-11.51%
2017-12-31$48.59M34.44%
2016-12-31$36.15M126.24%
2015-12-31$15.98M100.00%
2014-12-31-100.00%
2013-12-31-100.00%
2012-12-31-100.00%
2011-12-31-100.00%
2010-12-31-100.00%
2009-12-31-100.00%
2008-12-31--100.00%
2007-12-31$750.71K125.30%
2006-12-31$333.20K-72.06%
2005-12-31$1.19M7.82%
2004-12-31$1.11M-12.87%
2003-12-31$1.27M-31.61%
2002-12-31$1.86M15.72%
2001-12-31$1.60M-27.16%
2000-12-31$2.20M32.61%
1999-12-31$1.66M-1.15%
1998-12-31$1.68M-39.61%
1997-12-31$2.78M37.40%
1996-12-31$2.02M68.68%
1995-12-31$1.20M500.00%
1994-12-31$200.00K-

Enveric Biosciences generated - in revenue during NA 2023, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Enveric Biosciences Revenue by Quarter

DateRevenueChange
2024-06-30-100.00%
2024-03-31--100.00%
2023-12-31$647.09K100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31--100.00%
2020-12-31$-26.34M-410.51%
2020-09-30$8.48M2.76%
2020-06-30$8.25M-14.03%
2020-03-31$9.60M5.93%
2019-12-31$9.06M-0.92%
2019-09-30$9.15M-16.94%
2019-06-30$11.02M3.08%
2019-03-31$10.69M3.92%
2018-12-31$10.28M-2.77%
2018-09-30$10.58M-4.51%
2018-06-30$11.08M0.12%
2018-03-31$11.06M-3.42%
2017-12-31$11.45M-8.58%
2017-09-30$12.53M2.13%
2017-06-30$12.27M-0.59%
2017-03-31$12.34M-0.37%
2016-12-31$12.39M23.15%
2016-09-30$10.06M50.42%
2016-06-30$6.69M-4.65%
2016-03-31$7.01M57.13%
2015-09-30$4.46M13.54%
2015-06-30$3.93M100.00%
2015-03-31-100.00%
2014-12-31-100.00%
2014-09-30-100.00%
2014-06-30-100.00%
2014-03-31-100.00%
2013-12-31-100.00%
2013-09-30-100.00%
2013-06-30-100.00%
2013-03-31-100.00%
2012-12-31-100.00%
2012-09-30-100.00%
2012-06-30-100.00%
2012-03-31-100.00%
2011-12-31-100.00%
2011-09-30-100.00%
2011-06-30-100.00%
2011-03-31-100.00%
2010-12-31-100.00%
2010-09-30-100.00%
2010-06-30-100.00%
2010-03-31-100.00%
2009-12-31-100.00%
2009-09-30-100.00%
2009-06-30-100.00%
2009-03-31-100.00%
2008-12-31-100.00%
2008-09-30-100.00%
2008-06-30-100.00%
2008-03-31-100.00%
2007-12-31--100.00%
2007-09-30$30.11K-

Enveric Biosciences generated - in revenue during Q2 2024, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Enveric Biosciences Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
CWBRCohBar--
AVROAVROBIO--
ZURAZura Bio--
ELEVElevation Oncology--
OCEAOcean Biomedical--
HEPAHepion Pharmaceuticals--
ENVBEnveric Biosciences--
EFTReFFECTOR Therapeutics--

ENVB Revenue FAQ


Enveric Biosciences's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. The company's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021. ENVB's yearly revenue for 2021 was $0, representing an increase of 100.00% compared to 2020.

Enveric Biosciences's quarterly revenue for Q2 2024 was $0, a 100.00% increase from the previous quarter (Q1 2024), and a 0% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $0, a -100.00% decrease from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023). ENVB's quarterly revenue for Q4 2023 was $647.09K, a 100.00% increase from the previous quarter (Q3 2023), and a 0% increase year-over-year (Q4 2022).

Enveric Biosciences's revenue growth rate for the last 3 years (2021-2023) was 0%, and for the last 5 years (2019-2023) was -100.00%.